Table 2.
Effect of STS treatment on fetal and placental outcomes.
| Fetal and Placental Outcome | CON (n = 13) |
STS (2 g) (n = 9) |
STS (3 g) (n = 8) |
p-Value |
|---|---|---|---|---|
| Fetal weight (g) | 2.13 ± 0.04 | 2.13 ± 0.07 | 2.01 ± 0.05 | 0.28 |
| Fetal crown-rump length (cm) | 3.06 ± 0.04 | 3.03 ± 0.05 | 3.11 ± 0.03 | 0.51 |
| Viable litter size (n) | 10.71 ± 0.6 | 11.2 ± 0.5 | 11.3 ± 0.4 | 0.68 |
| Fetal resorptions (%) | 8.4 ± 1.9 | 5.9 ± 2.4 | 3.0 ± 1.5 | 0.24 |
| Placental weight (g) | 0.50 ± 0.01 | 0.51 ± 0.01 | 0.53 ± 0.01 | 0.14 |
| Fetal/placental weight ratio | 4.31 ± 0.08 a | 4.27 ± 0.16 | 3.83 ± 0.07 a | <0.01 |
STS dose in grams STS per kg body weight per day. The p-value from one-way ANOVA is provided with similar superscripted letters indicating which treatment groups was significantly different from the control group in Dunnett’s multiple comparisons test. Data presented as mean ± S.E.M. CON, control; STS, sodium thiosulfate.